Ascend Wellness Holdings (AAWH) Shares Outstanding (Diluted Average) (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Shares Outstanding (Diluted Average) of $202.4 million in Q1 2026, down 0.51% quarter-over-quarter from $203.5 million in Q4 2025, and down 1.24% on a YoY basis from $205.0 million in Q1 2025.
Ascend Wellness Holdings (AAWH) Shares Outstanding (Diluted Average) (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Shares Outstanding (Diluted Average) history runs 7 years deep, the most recent figure standing at $202.4 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Diluted Average) fell 1.24% year-over-year to $202.4 million; the TTM figure through Mar 2026 stood at $202.4 million (down 1.24% YoY), while the FY2025 annual figure was $203.5 million, down 4.22% from the prior year.
- Shares Outstanding (Diluted Average) was $202.4 million for Q1 2026 at Ascend Wellness Holdings, down from $203.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $214.3 million in Q3 2024 to a low of $172.5 million in Q1 2022.
- Historically, Shares Outstanding (Diluted Average) has averaged $198.8 million across 5 years, with a median of $203.0 million in 2025.
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Diluted Average) jumped 62.05% in 2022, then slipped 5.28% in 2025.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $183.4 million in 2022, then grew by 8.6% to $199.2 million in 2023, then gained by 6.67% to $212.4 million in 2024, then declined by 4.22% to $203.5 million in 2025, then retreated by 0.51% to $202.4 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $202.4 million (Q1 2026), $203.5 million (Q4 2025), and $203.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 103.40 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | - |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 101.11 Mn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | 202.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 202.45 Mn |
| Dec 31, 2025 | 203.48 Mn |
| Sep 30, 2025 | 202.97 Mn |
| Jun 30, 2025 | 203.87 Mn |
| Mar 31, 2025 | 205.00 Mn |
| Dec 31, 2024 | 212.43 Mn |
| Sep 30, 2024 | 214.29 Mn |
| Jun 30, 2024 | 211.06 Mn |
| Mar 31, 2024 | 208.95 Mn |
| Dec 31, 2023 | 199.15 Mn |
| Sep 30, 2023 | 205.71 Mn |
| Jun 30, 2023 | 192.07 Mn |
| Mar 31, 2023 | 188.49 Mn |
| Dec 31, 2022 | 183.38 Mn |
| Sep 30, 2022 | 187.70 Mn |
| Jun 30, 2022 | 185.31 Mn |
| Mar 31, 2022 | 172.49 Mn |
| Dec 31, 2021 | 149.43 Mn |
| Sep 30, 2021 | 169.88 Mn |
| Jun 30, 2021 | 150.34 Mn |